Wright Medical Group N.V. (WMGI) Analysts See $-0.06 EPS

April 17, 2018 - By Michael Collier

Wright Medical Group N.V. (NASDAQ:WMGI) Logo

Analysts expect Wright Medical Group N.V. (NASDAQ:WMGI) to report $-0.06 EPS on May, 2.They anticipate $0.03 EPS change or 33.33 % from last quarter’s $-0.09 EPS. After having $0.10 EPS previously, Wright Medical Group N.V.’s analysts see -160.00 % EPS growth. The stock decreased 1.65% or $0.34 during the last trading session, reaching $20.26. About 650,030 shares traded. Wright Medical Group N.V. (NASDAQ:WMGI) has declined 36.24% since April 18, 2017 and is downtrending. It has underperformed by 47.79% the S&P500.

Wright Medical Group N.V. (NASDAQ:WMGI) Ratings Coverage

Among 6 analysts covering Wright Medical Group NV (NASDAQ:WMGI), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Wright Medical Group NV had 14 analyst reports since November 2, 2017 according to SRatingsIntel. Barclays Capital maintained Wright Medical Group N.V. (NASDAQ:WMGI) on Thursday, November 2 with “Overweight” rating. The stock of Wright Medical Group N.V. (NASDAQ:WMGI) has “Outperform” rating given on Thursday, November 2 by BMO Capital Markets. The stock of Wright Medical Group N.V. (NASDAQ:WMGI) earned “Buy” rating by Cantor Fitzgerald on Monday, February 12. Robert W. Baird maintained it with “Buy” rating and $28.0 target in Wednesday, February 28 report. Cantor Fitzgerald maintained Wright Medical Group N.V. (NASDAQ:WMGI) on Monday, January 8 with “Buy” rating. The stock has “Buy” rating by Piper Jaffray on Wednesday, February 28. The rating was maintained by RBC Capital Markets on Wednesday, January 17 with “Buy”. The rating was maintained by Piper Jaffray on Tuesday, January 2 with “Buy”. The firm has “Buy” rating given on Monday, March 12 by Cantor Fitzgerald. BMO Capital Markets maintained the shares of WMGI in report on Wednesday, February 28 with “Outperform” rating.

Wright Medical Group N.V., a medical device company, designs, makes, markets, and sells extremities and biologics products.in the United States, Europe, the Middle East, Africa, and internationally. The company has market cap of $2.15 billion. The firm offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It currently has negative earnings. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries.

Wright Medical Group N.V. (NASDAQ:WMGI) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.